Oppenheimer Maintains Their Buy Rating on Model N (MODN)

In a report released today, Koji Ikeda from Oppenheimer maintained a Buy rating on Model N (MODN – Research Report), with a price target of $23. The company’s shares closed on Friday More »

Credit Suisse Remains a Buy on AstraZeneca (AZN)

According to The Fly, in a report issued on December 7, Matthew Weston from Credit Suisse maintained a Buy rating on AstraZeneca (AZN – Research Report). The company’s shares closed on Friday More »